Title: Dutasteride Prevents Clinical Progression of Benign Prostatic Hyperplasia in Minimally Symptomatic Men
Abstract: The 5α-reductase inhibitor dutasteride is used to treat men with symptomatic benign prostatic hyperplasia (BPH). Investigators assessed whether dutasteride prevents clinical progression of BPH in minimally symptomatic men with enlarged prostate glands.
The study involved 1600 men with prostate gland size >40 cc …
Publication Year: 2013
Publication Date: 2013-05-02
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot